PPH holdings

Holdings

#	Holding	Type	Weight	Value	Shares / par	Country
1	LLYEli Lilly & Co.	Equity	20.95%	$215M	183,661	US
2	MRKMerck & Co., Inc.	Equity	13.07%	$134M	941,328	US
3	NVONovo-Nordisk A/S	Equity	5.65%	$58M	1,517,037	DK
4	PFEPfizer Inc.	Equity	5.04%	$52M	1,858,109	US
5	MCKMcKesson Corporation	Equity	4.73%	$48M	52,102	US
6	TEVATeva Pharmaceutical Industries Limited	Equity	4.72%	$48M	1,232,549	IL
7	BMYBristol-Myers Squibb Co.	Equity	4.66%	$48M	801,401	US
8	CORCencora, Inc.	Equity	4.50%	$46M	143,683	US
9	GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	Equity	4.34%	$44M	955,307	GB
10	HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)	Equity	3.80%	$39M	4,211,381	GB
11	ABBVABBVIE INC.	Equity	3.78%	$39M	142,358	US
12	NVSNovartis AG	Equity	3.63%	$37M	259,818	CH
13	AZNAstraZeneca PLC	Equity	3.52%	$36M	227,602	GB
14	JNJJohnson & Johnson	Equity	3.35%	$34M	133,740	US
15	SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	Equity	3.27%	$34M	833,593	FR
16	TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	Equity	2.77%	$28M	1,530,786	JP
17	ZTSZOETIS INC.	Equity	2.59%	$27M	363,458	US
18	VTRSViatris Inc. Common Stock	Equity	1.48%	$15M	869,598	US
19	JAZZJazz Pharmaceuticals, Inc.	Equity	1.27%	$13M	58,543
20	CORTCorcept Therapeutics Inc.	Equity	0.79%	$8.1M	68,604	US
21	AXSMAxsome Therapeutics, Inc	Equity	0.68%	$6.9M	40,820	US
22	ELANElanco Animal Health Incorporated Common Stock	Equity	0.50%	$5.1M	228,068	US
23	DFTXDefinium Therapeutics, Inc. Common Shares	Equity	0.44%	$4.5M	131,653
24	OGNOrganon & Co.	Equity	0.29%	$3.0M	216,367	US
25	Other/Cash	Cash	0.12%	$1.2M	—
26	PRGOPERRIGO COMPANY PLC	Equity	0.10%	$1.1M	74,159
27	Cash	Cash	-0.03%	−$355K	-354,642

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Position changes between reports

Action	Holding	Weight before	Weight after	Shares vs flows	Between reports
Decrease	LLYEli Lilly & Co	18.70%	20.23%	−13.8%	Mar 31, 2026 → Jun 30, 2026 SEC
Decrease	NVONovo Nordisk A/S	4.81%	5.37%	−11.1%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	Jazz Pharmaceuticals PLC	0.80%	1.08%	+10.0%	Mar 31, 2026 → Jun 30, 2026 SEC
Increase	MCKMcKesson Corp	4.24%	4.12%	+15.8%	Mar 31, 2026 → Jun 30, 2026 SEC
New position	AstraZeneca PLC	—	4.40%	—	Dec 31, 2025 → Mar 31, 2026 SEC
Exit	AZNAstraZeneca PLC	4.34%	—	—	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	TEVATeva Pharmaceutical Industries Ltd	2.60%	2.83%	+11.1%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	Jazz Pharmaceuticals PLC	0.63%	0.80%	+12.2%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	ELANElanco Animal Health Inc	0.43%	0.35%	−23.4%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	BMYBristol-Myers Squibb Co	4.55%	4.62%	−10.9%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	CORTCorcept Therapeutics Inc	0.17%	0.22%	+10.7%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	AXSMAxsome Therapeutics Inc	0.49%	0.51%	+11.0%	Dec 31, 2025 → Mar 31, 2026 SEC
Increase	BHCBausch Health Cos Inc	0.11%	0.10%	+19.2%	Dec 31, 2025 → Mar 31, 2026 SEC
Decrease	JNJJohnson & Johnson	4.33%	4.34%	−16.4%	Dec 31, 2025 → Mar 31, 2026 SEC

Share-count changes are measured after removing what creations and redemptions explain.

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.